Showing all 2 results
Lamotrigine Tablets
FreeProduct Composition & Available Strengths
Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamotrigine USP / BP / IP 25 mg Oral Solid Uncoated / Dispersible Tablet Dermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase. Lamotrigine USP / BP / IP 50 mg Oral Solid Uncoated / Dispersible Tablet Intermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics. Lamotrigine USP / BP / IP 100 mg Oral Solid Compressed Tablet Standard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization. Lamotrigine USP / BP / IP 200 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies. Olanzepine Tablet
FreeProduct Composition & Available Strengths
We supply Olanzapine in standard, exact strengths to facilitate initial titration phases and safe daily maintenance therapy.
Active Ingredient Available Strengths Primary Clinical Target Olanzapine IP / BP / USP 2.5 mg Introductory Titration: For low-dose introductory cycles, elderly adjustment, or sensitive patient profiles. Olanzapine IP / BP / USP 5 mg Standard Maintenance: The baseline daily dosage for long-term schizophrenic and bipolar maintenance. Olanzapine IP / BP / USP 10 mg Acute Crisis Control: High-potency therapeutic dosing to stabilize acute manic or severe psychotic episodes.
